Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

BNTX

BioNTech SE ADR

Sep 15 • 03:29PM ET

97.58

+0.84 0.87 %

Healthcare • Biotechnology • Germany • NASD

Peers: MRNA PFE NVAX AZN JNJ GSK BMY GILD LLY SNY

| Held by: IBB FBT FNDF TCAF CGGR BBH SPDW IDNA QQQJ BBEU

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.60	Insider Own	1.52%	Shs Outstand	240.40M	Perf Week	-4.95%
Market Cap	23.46B	Forward P/E	-	EPS next Y	-4.34	Insider Trans	0.00%	Shs Float	236.74M	Perf Month	-13.42%
Enterprise Value	7.74B	PEG	-	EPS next Q	-1.22	Inst Own	22.01%	Short Float	2.54%	Perf Quarter	-8.44%
Income	-381.72M	P/S	7.51	EPS this Y	-75.68%	Inst Trans	3.40%	Short Ratio	7.28	Perf Half Y	-1.90%
Sales	3.13B	P/B	1.08	EPS next Y	23.93%	ROA	-1.55%	Short Interest	6.02M	Perf YTD	-14.37%
Book/sh	90.36	P/C	1.46	EPS next 5Y	-12.89%	ROE	-1.81%	52W High	131.49 -25.79%	Perf Year	-1.70%
Cash/sh	66.69	P/FCF	-	EPS past 3/5Y	- -25.87%	ROIC	-1.74%	52W Low	81.20 20.17%	Perf 3Y	-33.71%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-49.00% 89.57%	Gross Margin	79.80%	Volatility	6.05% 3.51%	Perf 5Y	65.28%
Dividend TTM	-	EV/Sales	2.48	EPS Y/Y TTM	30.53%	Oper. Margin	-18.52%	ATR (14)	4.37	Perf 10Y	-
Dividend Ex-Date	Jun 02, 2022	Quick Ratio	8.48	Sales Y/Y TTM	7.51%	Profit Margin	-12.21%	RSI (14)	38.94	Recom	1.61
Dividend Gr. 3/5Y	- -	Current Ratio	8.61	EPS Q/Q	50.13%	SMA20	-6.76%	Beta	1.46	Target Price	141.23
Payout	-	Debt/Eq	0.01	Sales Q/Q	113.52%	SMA50	-10.27%	Rel Volume	1.48	Prev Close	96.74
Employees	6772	LT Debt/Eq	0.01	Earnings	Aug 04 BMO	SMA200	-9.89%	Avg Volume	826.08K	Price	97.58
IPO	Oct 10, 2019	Option/Short	Yes / Yes	EPS/Sales Surpr.	28.90% 70.34%	Trades		Volume	1,129,655	Change	0.87%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-05-25	Reiterated	H.C. Wainwright	Buy	$134 → $145
May-29-25	Initiated	Goldman	Neutral	$110
Mar-13-25	Initiated	Citigroup	Buy	$145
Jan-10-25	Initiated	Truist	Buy	$172
Dec-11-24	Initiated	Wells Fargo	Overweight	$170
Dec-02-24	Reiterated	BMO Capital Markets	Outperform
Nov-19-24	Upgrade	Evercore ISI	In-line → Outperform	$110 → $125
Nov-19-24	Initiated	Berenberg	Buy	$130
Nov-08-24	Upgrade	Goldman	Neutral → Buy	$90 → $137
Sep-24-24	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$93 → $145
Sep-17-24	Upgrade	Jefferies	Hold → Buy	$96 → $150
Sep-16-24	Upgrade	JP Morgan	Underweight → Neutral	$91 → $125
Aug-07-24	Upgrade	Deutsche Bank	Hold → Buy	$95
Aug-02-24	Upgrade	HSBC Securities	Hold → Buy
May-14-24	Initiated	Evercore ISI	In-line	$100
Feb-23-24	Initiated	BMO Capital Markets	Outperform	$127
Jan-05-24	Initiated	Oppenheimer	Perform
Dec-01-23	Downgrade	JP Morgan	Neutral → Underweight	$106 → $99
Oct-16-23	Downgrade	HSBC Securities	Buy → Hold	$124 → $111
Jul-14-23	Initiated	HSBC Securities	Buy	$124

Show Previous Ratings

Today 08:56AM	COVID-19 Vaccine Stocks Fall on Reports Linking Shots to Child Deaths (Zacks)
04:00AM	Moderna and BioNTech pioneered mRNA vaccines. But who will make a mark in therapeutics? (Pharma Voice)
Sep-14-25 01:16AM	BMO Capital Maintains a Buy on BioNTech SE (BNTX) (Insider Monkey)
Sep-13-25 01:56PM	Moderna shares hit a low after report suggests the FDA plans to tie COVID shots to child deaths (FastCompany)
Sep-12-25 07:43PM	Drugmakers Fall on Report US to Claim Covid Shot Killed Kids (Bloomberg) -7.26%
06:19PM	Loading…
06:19PM	Why BioNTech Stock Sank by More Than 7% Today (Motley Fool)
04:21PM	Vaccine Stocks Fall Following Report of Plans to Link Covid Shot With Child Deaths (The Wall Street Journal)
02:11PM	Vaccine Stocks Down Following Report of Plans to Link Covid Shot With Child Deaths (The Wall Street Journal)
01:37PM	COVID vaccine makers' shares fall as Trump officials to link shots to child deaths, report says (MarketWatch)
12:33PM	Pfizer, Moderna, BioNTech trade lower amid report of vaccine link to child deaths (Investing.com)
12:11PM	Trump officials to link child deaths to COVID shots, Washington Post reports (Reuters)
11:35AM	Stock Market Today: Investors await opening trade from Gemini, Via, and Legence (TheStreet)
09:08AM	BMY-BioNTech Partnership: A Potential Catalyst for Long-Term Gains? (Zacks)
Sep-11-25 01:01PM	Bristol Myers Squibb, BioNTech Announce Positive Interim Data from Phase 2 Trial of Pumitamig in Lung Cancer (Insider Monkey)
09:52AM	Bristol Myers Loses 19.2% in Six Months: Buy, Sell or Hold? (Zacks)
01:17PM	Loading…
Sep-09-25 01:17PM	SMMT Stock Plummets 25% on Regional Data Differences in NSCLC Study (Zacks)
Sep-08-25 06:12PM	Today's Moving Stocks: Planet Labs, EchoStar, Robinhood, Summit Therapeutics, BioNTech, CVS Health (TheStreet) -8.71%
04:08PM	Summit Therapeutics Crashes After Failing To Deliver Another Merck-Walloping Punch (Investor's Business Daily)
01:41PM	Amid Vaccine Controversy, Pfizer Says New Covid Shots Are Effective (Barrons.com)
11:26AM	Stock Market Today: Stocks rise as investors embrace supersized cut chances (TheStreet)
11:00AM	First Disclosure of Global Interim Phase 2 Data for BioNTech and Bristol Myers Squibb PD-L1xVEGF-A Bispecific Antibody Pumitamig (BNT327/BMS986545) in Patients with Extensive-Stage Small Cell Lung Cancer Shows Encouraging Antitumor Activity (GlobeNewswire)
06:45AM	Pfizer and BioNTech Announce Topline Data Demonstrating Robust Immune Response With Their LP.8.1-Adapted COVID-19 Vaccine 2025-2026 Formula (Business Wire)
Sep-05-25 04:41PM	Why BioNTech Stock Crushed the Market Today (Motley Fool) +8.66%
01:46PM	BioNTech and Dualitys ADC trumps Kadcyla, but analysts unimpressed (Clinical Trials Arena)
12:22PM	Analyst Report: BioNTech SE (Morningstar Research)
10:27AM	Shots Fired! After RFK Jr.'s Senate Grilling, Will Pfizer, Moderna Survive The Battle In D.C.? (Investor's Business Daily)
09:27AM	BioNTech Surges 10% On Promising Test Results For Its Cancer Smart Bomb (Investor's Business Daily)
09:09AM	BioNTech Advances On Positive Phase 3 Breast Cancer Drug Data (Benzinga)
Aug-31-25 08:40AM	Large-cap biotech is a sector to watch for investors: Analysts (Yahoo Finance)
Aug-28-25 07:55AM	FDA approves mRNA vaccines for new Covid-19 season amid political tension (Pharmaceutical Technology)
04:53AM	Loading…
04:53AM	BioNTech SE (BNTX) Teams Up with BMS in $11B Cancer Deal (Insider Monkey)
Aug-27-25 02:30PM	RFK Jr. Makes Good On Promise To End Covid Vaccine Mandate. BioNTech Tumbles. (Investor's Business Daily)
01:42PM	New Covid-19 Boosters Are Coming Soon. Not Everyone Will Be Eligible to Get One. (The Wall Street Journal)
12:50PM	Pfizer and BioNTechs COMIRNATY Receives U.S. FDA Approval for Adults 65 and Older and Individuals Ages 5 through 64 at Increased Risk for Severe COVID-19 (Business Wire)
Aug-26-25 08:31PM	Trump Administration Plans To Pull COVID-19 Vaccines Off Market 'Within Months' (Benzinga)
Aug-11-25 05:15AM	NHS England to expand trial access for head and neck cancer vaccine (Clinical Trials Arena)
04:19AM	GSK climbs after winning FDA priority review for oral gonorrhoea antibiotic (Investing.com)
Aug-08-25 07:54AM	BioNTech ends patent fight with mRNA rival CureVac ahead of buyout deal (BioPharma Dive)
04:01AM	Bio/Pharmaceutical Outsourcing Analysis Report, June 2025 Edition - ADCs on the Rise: MilliporeSigma, Lonza Invest in Manufacturing While BioNTech Adds CMOs Ahead of FDA Filing (GlobeNewswire)
03:31AM	GSK to Receive $370 Million in U.S. Patent Litigation Settlement (The Wall Street Journal)
Aug-06-25 09:18AM	BMY Stock Trades Near 52-Week Low: Time to Buy or Sell? (Zacks)
Aug-05-25 11:55AM	BioNTech price target raised to $185 from $181 at Clear Street (TipRanks)
11:47AM	Pfizer Q2 Earnings Beat Estimates, Oncology Drives Top-Line Growth (Zacks)
06:00AM	Lipid Nanoparticles Market Industry Trends, Key Growth Drivers, Challenges, Future Opportunities, and Regulatory Landscape 2025-2034 (GlobeNewswire)
03:00AM	BioNTech SE (BNTX) Q2 2025 Earnings Call Highlights: Revenue Surge and Strategic Partnerships ... (GuruFocus.com)
Aug-04-25 11:16PM	Analyst Report: BioNTech SE (Morningstar Research)
08:51AM	J&J Expects Better Top-Line Growth in 2H: Can It Achieve the Goal? (Zacks)
07:01AM	BioNTech Stock Rises as Drug Maker Beats Earnings Expectations. (Barrons.com)
06:51AM	BioNTech's Q2 revenues double on higher COVID vaccine sales (Reuters)
06:45AM	BioNTech Announces Second Quarter 2025 Financial Results and Corporate Update (GlobeNewswire)
Aug-03-25 02:00PM	Palantir, Advanced Micro, Walt Disney, Pfizer, ZoomInfo, and More Stocks to Watch This Week (Barrons.com)
Aug-01-25 01:21PM	MRNA Beats on Q2 Earnings & Sales, Stock Down on Lowered Sales View (Zacks)
11:23AM	Zoetis Gears Up to Report Q2 Earnings: Here's What to Expect (Zacks)
10:01AM	Buy, Sell or Hold Pfizer Stock? Key Tips Ahead of Q2 Earnings (Zacks)
08:44AM	Moderna's Key Patent Win Overshadowed By Gloomy Outlook (Benzinga)
Jul-31-25 12:18PM	Arm Holdings slips on guidance, AbbVie Q2 beat, Bristol-Myers outlook (Yahoo Finance Video)
11:43AM	Bristol Myers Beats on Q2 Earnings and Sales, Raises '25 Sales View (Zacks)
10:42AM	Bristol Myers Cuts Earnings Outlook As Legacy Drugs Face Generic Erosion (Benzinga)
08:57AM	Bristol Myers Beats Earnings Expectations. Its Still Optimistic About New Schizophrenia Drug. (Barrons.com)
07:57AM	Bristol Myers Squibb Cuts Full-Year Adjusted View, But Raises Revenue Expectations (The Wall Street Journal)
07:48AM	Bristol-Myers Squibb shares rise as Q2 results boosted by growth portfolio (Investing.com)
07:01AM	Bristol Myers posts better-than-expected second quarter results on strength of top sellers (Reuters)
Jul-30-25 12:00PM	BioNTech SE Sponsored ADR (BNTX) Is Up 4.81% in One Week: What You Should Know (Zacks)
11:07AM	Perrigo to Report Q2 Earnings: What's in Store for the Stock? (Zacks)
04:31AM	Cancer Vaccine Market Research Service Featuring the Top 5 Developers and Pipeline Activities - OncoTherapy Science, Inovio, BioNTech, Theravectys, and GlaxoSmithKline (GlobeNewswire)
Jul-29-25 10:00AM	Best Momentum Stocks to Buy for July 29th (Zacks)
08:26AM	Moderna to Report Q2 Earnings: Is a Beat in Store for the Stock? (Zacks)
06:52AM	New Strong Buy Stocks for July 29th (Zacks)
Jul-28-25 09:28AM	Should You Buy, Hold, or Sell BMY Stock Ahead of Q2 Earnings? (Zacks)
Jul-25-25 07:36AM	Bristol Myers shuffles its executive ranks with new CMO (BioPharma Dive)
02:30AM	Pfizer and BioNTech Receive Positive CHMP Opinion for LP.8.1-adapted COVID-19 Vaccine in the European Union (Business Wire)
Jul-24-25 10:49AM	Bristol Myers Gains 6.3% in a Month: Buy, Sell or Hold the Stock? (Zacks)
09:40AM	Has BioNTech (BNTX) Outpaced Other Medical Stocks This Year? (Zacks)
Jul-23-25 10:14AM	Here's What to Expect From Pfizer's Non-Oncology Drugs in Q2 Earnings (Zacks)
Jul-21-25 06:45AM	BioNTech to Report Second Quarter 2025 Financial Results and Corporate Update on August 4, 2025 (GlobeNewswire)
Jul-18-25 06:20AM	ADCs on the rise: MilliporeSigma, Lonza invest in manufacturing while BioNTech adds CMOs ahead of FDA filing (Pharmaceutical Technology)
Jul-17-25 08:30AM	BioNTech Announces Ryan Richardson to Step Down from the Management Board (GlobeNewswire)
Jul-16-25 08:41AM	Will Increased Expenses Affect Bristol Myers' Performance? (Zacks)
Jul-11-25 10:58AM	MRNA Stock Up on Full FDA Nod for COVID-19 Jab in Pediatric Patients (Zacks)
Jul-09-25 10:30AM	Recent Agreements Set To Bolster BioNTech SE (BNTX)'s Oncology Arm (Insider Monkey)
Jul-07-25 07:17AM	mRNA Cancer Vaccines Clinical Trials & Future Market Outlook 2025: Personalized mRNA Cancer Vaccines Revolutionize Oncology with Neoantigen-Driven Immunotherapy (GlobeNewswire)
Jul-04-25 09:00AM	How Much of Your Portfolio Should Be in International Stocks? (The Wall Street Journal)
Jun-30-25 09:50AM	BMY Loses 16.3% YTD: Should You Buy, Sell or Hold the Stock? (Zacks)
Jun-20-25 11:51AM	CureVac Soars 41% in a Month on a $1.25B Buyout Offer From BioNTech (Zacks)
Jun-13-25 12:15PM	Oracle reports Q4 beat, BioNTech to acquire CureVac: Morning Buzz (TipRanks)
08:16AM	BioNTech buys mRNA, courtroom rival CureVac in all-stock deal (BioPharma Dive)
Jun-12-25 12:49PM	BioNTech bolsters mRNA pipeline with $1.25bn CureVac acquisition (Pharmaceutical Technology)
12:11PM	Gold prices, BioNTech to acquire CureVac, Tapestry upgrade (Yahoo Finance Video)
10:25AM	COVID-19 Vaccine Maker BioNTech Buys CureVac as It Aims for Cancer Treatments (Investopedia)
10:20AM	BioNTech to Buy CureVac in $1.25 Billion Deal to Boost Its Cancer Business (Barrons.com)
09:15AM	BMY Reports Positive Data on Sotyktu From Arthritis Study (Zacks)
07:51AM	BioNTech to Acquire CureVac in Stock Deal Valued Around $1.25 Billion (The Wall Street Journal)
07:44AM	CureVac stock soars about 30% after BioNTech agrees to acquire co (Investing.com)
07:18AM	Stocks to Watch Thursday: Boeing, Oracle, GameStop, CureVac (The Wall Street Journal)
07:11AM	BioNTech to Buy CureVac in $1.25 Billion Deal. Both Stocks Are Rising. (Barrons.com)
06:58AM	BioNTech takes over CureVac in $1.25 billion all-stock deal among COVID rivals (Reuters)
06:45AM	BioNTech Announces Strategic Transaction to Acquire CureVac in Public Exchange Offer (GlobeNewswire)
Jun-11-25 10:20AM	Trump Trade: RFK Jr. removes members of vaccine-advising CDC panel (TipRanks)
Jun-10-25 04:10PM	Vaccine Stocks Mixed After RFK Jr. Fires CDC's Entire Vaccine Committee (Investor's Business Daily)
10:10AM	RFK Jr. removes CDC vaccine panel members: What to know (Yahoo Finance Video)

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	SEC Form 4
ATHOS KG	10% Owner	Sep 05 '25	Proposed Sale	112.46	500,000	56,230,000	Sep 05 04:41 PM
Medine GmbH	Officer	Aug 15 '25	Proposed Sale	112.70	1,774,837	200,024,130	Aug 15 08:27 AM
Tureci Ozlem	Officer	Aug 15 '25	Proposed Sale	112.70	185,001	20,849,613	Aug 15 08:22 AM
Jeggle Helmut Wolfgang	Director	Jun 04 '25	Proposed Sale	113.10	150,000	16,965,000	Jun 04 08:31 AM
ATHOS KG	10% Owner	Jun 02 '25	Proposed Sale	110.83	175,000	19,394,800	Jun 02 04:08 PM
ATHOS KG	10% Owner	May 28 '25	Proposed Sale	98.68	500,000	49,340,000	May 28 09:00 AM
Jeggle Helmut Wolfgang	Director	May 07 '25	Proposed Sale	94.74	150,000	14,211,000	May 07 07:30 AM
Richardson Ryan	Officer	Feb 27 '25	Proposed Sale	114.00	26,500	3,021,000	Feb 27 07:57 AM
Medine GmbH	Officer	Feb 20 '25	Proposed Sale	119.58	1,000,000	119,580,000	Feb 20 07:53 AM
Poetting Sierk	Officer	Feb 20 '25	Proposed Sale	119.58	120,000	14,349,600	Feb 20 07:50 AM
ATHOS KG	10% Owner	Dec 13 '24	Proposed Sale	120.69	4,983	601,398	Dec 13 05:56 PM
ATHOS KG	10% Owner	Dec 11 '24	Proposed Sale	116.85	22,450	2,623,283	Dec 11 05:25 PM
ATHOS KG	10% Owner	Dec 09 '24	Proposed Sale	121.72	53,716	6,538,312	Dec 09 06:35 PM
ATHOS KG	10% Owner	Dec 06 '24	Proposed Sale	118.84	13,104	1,557,279	Dec 06 05:57 PM
ATHOS KG	10% Owner	Nov 27 '24	Proposed Sale	118.54	44,374	5,260,094	Nov 27 05:50 PM
ATHOS KG	10% Owner	Nov 26 '24	Proposed Sale	120.76	10,000	1,207,600	Nov 26 06:37 PM
ATHOS KG	10% Owner	Nov 25 '24	Proposed Sale	113.13	75,000	8,484,750	Nov 25 05:06 PM
Jeggle Helmut Wolfgang	Director	Nov 15 '24	Proposed Sale	103.56	150,000	15,534,000	Nov 15 05:12 PM
Tureci Ozlem	Officer	Nov 12 '24	Proposed Sale	108.73	556,000	60,453,880	Nov 12 07:39 AM
ATHOS KG	10% Owner	Oct 16 '24	Proposed Sale	117.74	8,036	946,154	Oct 16 05:03 PM
ATHOS KG	10% Owner	Oct 14 '24	Proposed Sale	120.83	25,424	3,071,964	Oct 15 08:41 AM
ATHOS KG	10% Owner	Oct 11 '24	Proposed Sale	120.13	40,000	4,805,228	Oct 11 04:15 PM
ATHOS KG	10% Owner	Oct 10 '24	Proposed Sale	117.47	20,000	2,349,436	Oct 10 04:13 PM
ATHOS KG	10% Owner	Oct 09 '24	Proposed Sale	119.06	6,000	714,361	Oct 09 04:02 PM
ATHOS KG	10% Owner	Oct 08 '24	Proposed Sale	122.01	15,000	1,830,100	Oct 08 04:24 PM
ATHOS KG	10% Owner	Oct 04 '24	Proposed Sale	122.80	14,756	1,812,078	Oct 04 04:17 PM
ATHOS KG	10% Owner	Oct 03 '24	Proposed Sale	119.27	50,000	5,963,585	Oct 03 05:14 PM
ATHOS KG	10% Owner	Oct 02 '24	Proposed Sale	119.04	65,200	7,761,193	Oct 02 06:18 PM
ATHOS KG	10% Owner	Oct 01 '24	Proposed Sale	119.24	72,086	8,595,657	Oct 01 04:18 PM
ATHOS KG	10% Owner	Sep 30 '24	Proposed Sale	118.22	76,114	8,998,197	Sep 30 04:52 PM
ATHOS KG	10% Owner	Sep 27 '24	Proposed Sale	117.64	37,204	4,376,679	Sep 27 05:12 PM
ATHOS KG	10% Owner	Sep 25 '24	Proposed Sale	118.47	37,943	4,495,107	Sep 25 07:14 PM
ATHOS KG	10% Owner	Sep 18 '24	Proposed Sale	124.71	55,605	6,934,500	Sep 18 07:28 PM
ATHOS KG	10% Owner	Sep 17 '24	Proposed Sale	124.49	30,162	3,754,792	Sep 17 04:14 PM
ATHOS KG	10% Owner	Sep 16 '24	Proposed Sale	123.40	500,000	61,700,000	Sep 16 05:35 PM
ATHOS KG	10% Owner	Sep 16 '24	Proposed Sale	126.02	90,000	11,341,611	Sep 16 04:12 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

BNTX

BioNTech SE ADR

Upgrade your FINVIZ experience